These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 2557985

  • 1. Pyrimidine 5'-nucleotidase deficiency: improved detection of carriers.
    de Korte D, Sijstermans JM, Seip M, van Doorn CC, van Gennip AH, Roos D.
    Clin Chim Acta; 1989 Sep 29; 184(2):175-80. PubMed ID: 2557985
    [Abstract] [Full Text] [Related]

  • 2. Chronic non-spherocytic haemolytic anaemia due to congenital pyrimidine 5' nucleotidase deficiency: 25 years later.
    Vives i Corrons JL.
    Baillieres Best Pract Res Clin Haematol; 2000 Mar 29; 13(1):103-18. PubMed ID: 10916681
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase deficiency.
    Kanno H, Takizawa T, Miwa S, Fujii H.
    Br J Haematol; 2004 Jul 29; 126(2):265-71. PubMed ID: 15238149
    [Abstract] [Full Text] [Related]

  • 7. [Pyrimidine 5'-nucleotidase deficiency as the congenital cause of nonspherocytic hemolytic anemia].
    Pekrun A, Lakomek M, Eng W, Schröter W.
    Dtsch Med Wochenschr; 1993 Sep 10; 118(36):1276-80. PubMed ID: 8375297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pyrimidine-5'-nucleotidase anomaly].
    Miwa S.
    Tanpakushitsu Kakusan Koso; 1988 Apr 10; 33(5):625-8. PubMed ID: 2855950
    [No Abstract] [Full Text] [Related]

  • 10. Proteomics reveals reduced expression of transketolase in pyrimidine 5'-nucleotidase deficient patients.
    Barasa BA, van Oirschot BA, Bianchi P, van Solinge WW, Heck AJ, van Wijk R, Slijper M.
    Proteomics Clin Appl; 2016 Aug 10; 10(8):859-69. PubMed ID: 27381654
    [Abstract] [Full Text] [Related]

  • 11. [Hemolytic anemia caused by pyrimidine 5'-nucleotidase (P5N) deficiency 15 years later. Apropos of 2 new cases of hereditary deficit and another one of lead poisoning].
    de la Serna FJ, Gilsanz F, Ricard P, Urrutia A.
    Med Clin (Barc); 1989 Oct 07; 93(10):380-2. PubMed ID: 2558262
    [Abstract] [Full Text] [Related]

  • 12. Pyrimidine-5'-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5'-nucleotidase type I deficiency and influence of Gilbert's Syndrome on clinical expression.
    Santos Ad, Dantas LE, Traina F, Albuquerque DM, Chaim EA, Saad ST.
    Blood Cells Mol Dis; 2014 Dec 07; 53(4):246-52. PubMed ID: 25153905
    [Abstract] [Full Text] [Related]

  • 13. A new simple approach for the determination of pyrimidine 5'-nucleotidase activity in human erythrocytes using an ELISA reader.
    Warang P, Kedar P, Ghosh K, Colah R.
    Int J Lab Hematol; 2012 Jun 07; 34(3):232-6. PubMed ID: 22078096
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Congenital non spherocytic hemolytic anemia (CNSHA) due to pyrimidine 5' nucleotidase deficiency.
    Aparna KR, Elizabeth KE.
    Indian Pediatr; 2006 Feb 07; 43(2):184-5. PubMed ID: 16528122
    [No Abstract] [Full Text] [Related]

  • 16. Distribution of erythrocyte nucleotides in pyrimidine 5'-nucleotidase deficiency.
    Torrance JD, Whittaker D.
    Br J Haematol; 1979 Nov 07; 43(3):423-34. PubMed ID: 497119
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The genetic basis of the interaction between pyrimidine 5' nucleotidase I deficiency and hemoglobin E.
    Escuredo E, Marinaki AM, Duley JA, Thein SL, Rees DC.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 07; 23(8-9):1261-3. PubMed ID: 15571242
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y, Harada K, Ohmori S, Lee BK, Miura H, Ueda A.
    Occup Environ Med; 1995 Jul 07; 52(7):484-8. PubMed ID: 7670624
    [Abstract] [Full Text] [Related]

  • 20. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA, Zerez CR, Tanaka KR.
    Biochim Biophys Acta; 1989 Jan 19; 994(1):81-8. PubMed ID: 2535789
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.